Search results for "protocols"

showing 10 items of 782 documents

Combination chemotherapy with mitomycin C, vindesine and melphalan for refractory metastatic breast cancer.

1991

A combination of mitomycin C, vindesine and melphalan was administered to 33 patients with heavily pretreated refractory breast cancer. The overall response rate was 27% with a mean duration of more than 10.2 months. A stabilization with a mean duration of 5.1 months was seen in 56% of cases, while 20% of patients progressed. Gastrointestinal toxicity, mostly grade 1 or 2 nausea/vomiting was seen in 85% of cases, grade 1 or 2 leukopenia in 60% of patients, and grade 1 or 2 thrombocytopenia in 42%. Considering the good compliance of this regimen and the poor prognosis of patients with refractory advanced breast cancer, this combination can be useful as a palliative treatment of breast carcin…

MelphalanOncologyAdultCancer Researchmedicine.medical_specialtyVindesinemedicine.medical_treatmentMitomycinBreast NeoplasmsMitomycinsBreast cancerInternal medicineAntineoplastic Combined Chemotherapy ProtocolsMedicineHumansNeoplasm MetastasisMelphalanAgedChemotherapybusiness.industryMitomycin CPalliative CareCancerCombination chemotherapyGeneral MedicineMiddle Agedmedicine.diseaseMetastatic breast cancerOncologyVindesineFemalebusinessmedicine.drugJournal of cancer research and clinical oncology
researchProduct

Adaptogens in chemobrain (Part III): Antitoxic effects of plant extracts towards cancer chemotherapy-induced toxicity - transcriptome-wide microarray…

2019

Abstract Background Toxicity of chemotherapeutics is a serious problem in cancer therapy. Adaptogens are known to increase adaptability and survival organisms. Aim The aim of this study was to assess the effects of selected adaptogenic herbal extracts on FEC (fixed combination of 5-fluorouracil, epirubicin and cyclophosphamide) induced changes in transcriptome-wide microarray profiles of neuroglia cells. Another task of the study was to identify those genes, which are associated with FEC-induced hepato-, cardio– and nephrotoxicity to predict potential effects of andrographolide (AND), Andrographis herb, Eleutherococcus roots genuine extracts (ES), their fixed combination (AE) and the combin…

MicroarrayDNA repairPharmaceutical ScienceAntineoplastic AgentsEleutherococcusBiologyPharmacologyPlant RootsTranscriptome03 medical and health sciences0302 clinical medicineDrug DiscoveryAntineoplastic Combined Chemotherapy ProtocolsHumansCyclophosphamideCells Cultured030304 developmental biologySchisandraPharmacology0303 health sciencesMicroarray analysis techniquesPlant ExtractsLiver cellGene Expression ProfilingMicroarray AnalysisGene expression profilingComplementary and alternative medicineApoptosis030220 oncology & carcinogenesisFruitToxicityMolecular MedicineRhodiolaAntitoxinsFluorouracilTranscriptomeNeurogliaPhytomedicine : international journal of phytotherapy and phytopharmacology
researchProduct

Adaptogens in chemobrain (Part I): Plant extracts attenuate cancer chemotherapy-induced cognitive impairment – Transcriptome-wide microarray profiles…

2019

Abstract Background Cancer chemotherapy-induced cognitive impairments are presumably associated with undesirable effects of chemotherapy on physiological functions of brain cells. Adaptogens are natural compounds or plant extracts increasing an organism's adaptability and survival in stress. They exhibited neuroprotective effects and increased cognitive functions in clinical studies in human beings. Hypothesis We hypothesized that selected adaptogenic plant extracts attenuate or prevent cancer chemotherapy-induced cognitive impairments. Aim We assessed the effects of selected adaptogenic herbal extracts on FEC (fixed combination 5-fluorouracil, epirubicin and cyclophosphamide) induced chang…

MicroarrayPharmaceutical ScienceBiologyPharmacologyNeuroprotectionCell LineTranscriptome03 medical and health sciences0302 clinical medicineAntineoplastic Combined Chemotherapy ProtocolsDrug DiscoverymedicineHumansCognitive DysfunctionCyclophosphamideEpirubicinOligonucleotide Array Sequence AnalysisSchisandra030304 developmental biologyPharmacology0303 health sciencesPlant ExtractsMicroarray analysis techniquesGene Expression ProfilingAxon extensionNeurogenesisGene expression profilingmedicine.anatomical_structureGene Expression RegulationComplementary and alternative medicineFruit030220 oncology & carcinogenesisMolecular MedicineNeurogliaAndrographisNeurotoxicity SyndromesRhodiolaFluorouracilDiterpenesNeurogliaPhytomedicine
researchProduct

Verifying a medical protocol with temporal graphs: the case of a nosocomial disease.

2014

Abstract Objective Our contribution focuses on the implementation of a formal verification approach for medical protocols with graphical temporal reasoning paths to facilitate the understanding of verification steps. Materials and methods Formal medical guideline specifications and background knowledge are represented through conceptual graphs, and reasoning is based on graph homomorphism. These materials explain the underlying principles or rationale that guide the functioning of verifications. Results An illustration of this proposal is made using a medical protocol defining guidelines for the monitoring and prevention of nosocomial infections. Such infections, which are acquired in the h…

Model checking[ INFO.INFO-MO ] Computer Science [cs]/Modeling and SimulationComputation tree logicTheoretical computer scienceComputer scienceModel checking Medical protocolMédecine humaine et pathologieCritical Care and Intensive Care MedicineMedical guidelineConsistency (database systems)Clinical Protocols[ SDV.MHEP ] Life Sciences [q-bio]/Human health and pathologyDrug Resistance BacterialHumansFormal verificationProblem SolvingProtocol (science)Cross Infectionbusiness.industryVisual informationModels TheoreticalModélisation et simulationNosocomial diseases[INFO.INFO-MO]Computer Science [cs]/Modeling and SimulationConceptual graphsCatheter-Related InfectionsConceptual graphCarrier StateVisual modelingDisease SusceptibilitySoftware engineeringbusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyAlgorithmsJournal of critical care
researchProduct

Identification of Synaptic Integration Mode in CA3 Pyramidal Neuron Model

2019

International audience; A morphologically realistic and anisotropic model of CA3 pyramidal neuron was developed to determine the synaptic integration modes the neuron is able to perform. Linearity and nonlinearity were identified in different synaptic locations with varying active mechanisms such as the presence of ionic channels in the dendritic arbor and the types of receptors in the synapse. Quantification of synaptic integration was performed using paired-pulse stimulation protocol and subthreshold input/output (sI/O) transformation. Results show that the mode of synaptic integration is location-dependent while the linearity or nonlinearity in the integration is mainly influenced by the…

MorphologyShaftsionic channelsResistancereceptorstwo-layer networksynaptic integration modesimple CA3 pyramidal neuronSynapselinear integrationdendritic arbormedicinesynaptic locationsCA3 pyramidal neuron model[SDV.IB] Life Sciences [q-bio]/BioengineeringNeuronsbiomembrane transportcomputational powerPhysicssubthreshold input-output transformationSynaptic integrationSubthreshold conductionmorphologically realistic modelMode (statistics)Linearitypaired-pulse stimulation protocolactive channelsanisotropic modelNonlinear systemmedicine.anatomical_structurenervous systemsublinear integrationCa3 pyramidal neuronbioelectric phenomena[SDV.IB]Life Sciences [q-bio]/BioengineeringAction potentialsNeuronneurophysiologysupralinear integrationNeuroscienceNeckProtocols2019 9th International IEEE/EMBS Conference on Neural Engineering (NER)
researchProduct

Progressive active mobilization with dose control and training load in critically ill patients (PROMOB): Protocol for a randomized controlled trial

2020

The dose of progressive active mobilization is still uncertain. The purpose of this study is to identify if the addition of a protocol of progressive active mobilization with dose and training load control to usual care is effective in reducing the length of stay in intensive care unit (ICU) and the improvement of the functioning, incidence of ICU-acquired weakness (ICUAW), mechanical ventilation duration and mortality rate in patients hospitalized in ICU. It is Double-blind randomised clinical trial. The setting for this trial will be medical and surgical ICU of a university hospital. The study participants will be 118 patients aged> 18 years admitted to ICU for less than 72 hours. Partici…

Muscle PhysiologyMuscle FunctionsPhysiologymedicine.medical_treatmentHamstring MusclesKaplan-Meier EstimateQuadriceps Musclelaw.inventionMathematical and Statistical Techniques0302 clinical medicineClinical ProtocolsRandomized controlled triallawMedicine and Health SciencesPublic and Occupational Health030212 general & internal medicineYoung adultRandomized Controlled Trials as TopicMultidisciplinaryMortality rateStatisticsQRMetaanalysisIntensive care unitSports ScienceHospitalsIntensive Care UnitsStrength TrainingPhysical SciencesMedicinemedicine.symptomAdultWeaknessmedicine.medical_specialtyDrug Research and DevelopmentDeath RatesStrength trainingCritical IllnessScienceResearch and Analysis MethodsYoung Adult03 medical and health sciencesDouble-Blind MethodPopulation MetricsRegistered Report ProtocolmedicineHumansClinical TrialsMuscle StrengthSports and Exercise MedicineStatistical MethodsExercisePharmacologyMechanical ventilationPopulation Biologybusiness.industryBiology and Life Sciences030208 emergency & critical care medicinePhysical ActivityLength of StayRespiration ArtificialRandomized Controlled TrialsHealth CareClinical trialPhysical FitnessHealth Care FacilitiesPhysical therapyClinical MedicinebusinessMathematicsPLOS ONE
researchProduct

Synergistic targeting of FLT3 mutations in AML via combined menin-MLL and FLT3 inhibition

2020

Abstract The interaction of menin (MEN1) and MLL (MLL1, KMT2A) is a dependency and provides a potential opportunity for treatment of NPM1-mutant (NPM1mut) and MLL-rearranged (MLL-r) leukemias. Concomitant activating driver mutations in the gene encoding the tyrosine kinase FLT3 occur in both leukemias and are particularly common in the NPM1mut subtype. In this study, transcriptional profiling after pharmacological inhibition of the menin-MLL complex revealed specific changes in gene expression, with downregulation of the MEIS1 transcription factor and its transcriptional target gene FLT3 being the most pronounced. Combining menin-MLL inhibition with specific small-molecule kinase inhibitors…

NPM1Transcription GeneticImmunologyApoptosisBiochemistryMiceRandom AllocationMice Inbred NODCell Line TumorProto-Oncogene Proteinshemic and lymphatic diseasesAntineoplastic Combined Chemotherapy ProtocolsGene expressionmedicineAnimalsHumansMEN1PhosphorylationMyeloid Ecotropic Viral Integration Site 1 ProteinProtein Kinase InhibitorsneoplasmsbiologyGene Expression Regulation LeukemicKinaseNuclear ProteinsMyeloid leukemiaDrug SynergismHistone-Lysine N-MethyltransferaseCell BiologyHematologymedicine.diseaseCoculture TechniquesNeoplasm ProteinsLeukemia Myeloid AcuteLeukemiaKMT2Afms-Like Tyrosine Kinase 3biology.proteinCancer researchNucleophosminProtein Processing Post-TranslationalTyrosine kinaseMyeloid-Lymphoid Leukemia ProteinBlood
researchProduct

The effects of computer-based mindfulness training on Self-control and Mindfulness within Ambulatorily assessed network Systems across Health-related…

2016

Background Self-control is an important ability in everyday life, showing associations with health-related outcomes. The aim of the Self-control and Mindfulness within Ambulatorily assessed network Systems across Health-related domains (SMASH) study is twofold: first, the effectiveness of a computer-based mindfulness training will be evaluated in a randomized controlled trial. Second, the SMASH study implements a novel network approach in order to investigate complex temporal interdependencies of self-control networks across several domains. Methods The SMASH study is a two-armed, 6-week, non-blinded randomized controlled trial that combines seven weekly laboratory meetings and 40 days of e…

Network approachMedicine (miscellaneous)Ambulatory assessmentStudy ProtocolClinical ProtocolsSelf-controlRandomized controlled trialSample Size150 PsychologieHumansPharmacology (medical)Students150 PsychologyMindfulnessTrials
researchProduct

Minimally invasive secondary cytoreduction plus HIPEC for recurrent ovarian cancer: a case series.

2014

Objective To analyze the feasibility of laparoscopic/robotic secondary cytoreductive surgery and hyperthermic intraperitoneal intra-operative chemotherapy (SCS + HIPEC) in a retrospective series of isolated platinum sensitive recurrent ovarian cancer. Methods We retrospectively evaluated a consecutive series of ovarian cancer patients with isolated platinum sensitive relapse. Isolated relapse was defined as the presence of a single nodule, in a single anatomic site. In all cases the presence of isolated relapse was assessed at pre-operative FDG-PET/CT scan, and confirmed with staging laparoscopy performed immediately before SCS + HIPEC. Results 84 women with platinum sensitive relapse recei…

OVARIAN CANEROrganoplatinum Compoundsmedicine.medical_treatmentdrug therapy/pathology/surgery/therapyCarcinoma Ovarian EpithelialMultimodal ImagingCohort StudiesObstetrics and gynaecologyNeoplasmsAntineoplastic Combined Chemotherapy ProtocolsInfusions ParenteralNeoplasms Glandular and EpithelialLaparoscopyadministration /&/ dosageTomographyRandomized Controlled Trials as TopicOvarian Neoplasmsmedicine.diagnostic_testObstetrics and GynecologyGlandular and EpithelialMiddle AgedDebulkingCombined Modality TherapyIsolated platinum sensitive relapseX-Ray ComputedOxaliplatinPhase III as TopicOncologyFemalediagnostic usemedicine.drugmedicine.medical_specialtyInfusionsAged Antineoplastic Combined Chemotherapy Protocols; administration /&/ dosage Cisplatin; administration /&/ dosage Clinical Trials; Phase II as Topic Clinical Trials; Phase III as Topic Cohort Studies Combined Modality Therapy Female Fluorodeoxyglucose F18; diagnostic use Humans Hyperthermia; Induced; methods Infusions; Parenteral Middle Aged Minimally Invasive Surgical Procedures Multimodal Imaging Neoplasms; Glandular and Epithelial; drug therapy/pathology/surgery/therapy Organoplatinum Compounds; administration /&/ dosage Ovarian Neoplasms; drug therapy/pathology/surgery/therapy Positron-Emission Tomography Radiopharmaceuticals; diagnostic use Randomized Controlled Trials as Topic Retrospective Studies Tomography; X-Ray Computed ocal; pathologyocalmethodsClinical Trials Phase II as TopicMinimally invasive surgeryOvarian cancerFluorodeoxyglucose F18ParenteralmedicineHumansMinimally Invasive Surgical ProceduresClinical TrialsHyperthermiaAgedRetrospective StudiesCisplatinChemotherapySeries (stratigraphy)HIPECbusiness.industryPhase II as TopicInducedHyperthermia Inducedmedicine.diseaseOxaliplatinSurgeryRoboticSettore MED/40 - GINECOLOGIA E OSTETRICIAClinical Trials Phase III as TopicPositron-Emission TomographyLaparoscopypathologyNeoplasm Recurrence LocalCisplatinRadiopharmaceuticalsbusinessOvarian cancerTomography X-Ray Computed
researchProduct

Conventional induction and post-remission therapy in APL: have we arrived?

2014

Since the introduction of all-trans-retinoic acid, the use of this molecularly targeted treatment in combination with anthracycline-based chemotherapy has completely changed the prognosis of acute promyelocytic leukemia (APL) turning it into the most curable acute myeloid leukemia. Also, the use of risk-adapted protocols has optimized the drug combination and the most appropriate dose intensity for each subset of patients classified according to both risk of relapse and vulnerability to drug toxicity. Recent developments have included the investigation of the role of arsenic trioxide (ATO) as front-line treatment after its success in relapsed APL, both to minimize or even omit the use of cy…

OncologyAcute promyelocytic leukemiaDrugmedicine.medical_specialtyHarringtoninesAnthracyclinemedia_common.quotation_subjectmedicine.medical_treatmentClinical BiochemistryTretinoinPharmacologyArsenicalsTargeted therapyMaintenance Chemotherapychemistry.chemical_compoundArsenic TrioxideLeukemia Promyelocytic AcuteInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansMulticenter Studies as TopicAnthracyclinesRelapse riskArsenic trioxidemedia_commonChemotherapyClinical Trials as Topicbusiness.industryMercaptopurineDaunorubicinRemission InductionMyeloid leukemiaOxidesmedicine.diseaseConsolidation ChemotherapyMethotrexateOncologychemistryMitoxantronebusinessHomoharringtonineIdarubicinBest practiceresearch. Clinical haematology
researchProduct